# David Schonthal

> David Schonthal is a Series C investor at Pritzker Group Venture Capital backing mHealth. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Pritzker Group Venture Capital](https://shizune.co/investors/profile/pritzker-group-venture-capital)
- Location: Chicago, United States
- Total investments: 1
- Last investment: Mar 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/schonthal

David Schonthal is a Clinical Assistant Professor of Entrepreneurship & Innovation at Northwestern University’s Kellogg School of Management where he teaches courses in new venture creation and leads the school’s internal startup accelerator – the Zell Scholars program. He also serves as a Business Designer at the global innovation and designconsultancy, IDEO, where he focuses on venture design and corporate entrepreneurship.David is also a co-founder of Fusion Ventures, an investment and advisory firm focused on growing technology startups in the early stages of their development. He was formerly Director of Strategy and Venture Development at Tavistock Life Sciences, a private investment firm located in San Diego, CA., and has held numerous senior management positions at startups in the technology and life sciences sectors. David began his career as a management consultant for Andersen, Deloitte and PricewaterhouseCoopers based in both the United States and United Kingdom.David serves as a member of Chicago Mayor Rahm Emanuel’s technology, innovation, and entrepreneurship council, ChicagoNext and was previously an advisor to the State of Illinois’s Invest Illinois Venture Capital Fund. He currently mentors and advises with several startup accelerators and incubators throughout the United States, including TechStars, CONNECT, San Diego Sports Innovators (SDSI), and Chicago Innovation Mentors.David earned his MBA from The Kellogg School of Management at Northwestern University and his B.A. in International Relations from Boston University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| mHealth | 1 | 100% |
| Hospital | 1 | 100% |
| Health Care | 1 | 100% |
| Mobile Devices | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CirrusMD | CirrusMD is a text-first enterprise solution that connects people and doctors with no-barriers access to human experts who can always help. It develops a solution to deliver guidance beyond primary care. The company was founded in 2012 and is headquartered in Denver, Colorado. | $20M | Series C | Mar 31, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Drive Capital](https://shizune.co/investors/profile/drive-capital) — VC Fund, 1 deal together
- [The Colorado Impact Fund](https://shizune.co/investors/profile/the-colorado-impact-fund) — VC Fund, 1 deal together

## About Pritzker Group Venture Capital

VC Fund · Chicago, United States

Pritzker Group Venture Capital helps entrepreneurs build market-leading technology companies at every stage of their growth. Since its founding in 1996, the firm has worked side-by-side with entrepreneurs at more than 100 companies, building partnerships based on trust and integrity. Its proprietary capital structure allows for tremendousflexibility, and our experienced team of investment professionals and entrepreneurs offers companies a vast network of strategic relationships and guidance.Successful exits in recent years include Fleetmatics (NYSE: FLTX), SinglePlatform (acquired by Constant Contact), Zinch (acquired by Chegg), Playdom (acquired by Disney), LeftHand Networks (acquired by Hewlett-Packard), and TicketsNow (acquired by Ticketmaster).

5 contacts available at Pritzker Group Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Chris Girgenti | Managing Partner | https://shizune.co/investors/profile/chris-girgenti-2 |
| David Schonthal | Venture Partner | https://shizune.co/investors/profile/david-schonthal |
| Adam Koopersmith | Partner | https://shizune.co/investors/profile/adam-c-koopersmith |
| Carter Cast | Venture Partner | https://shizune.co/investors/profile/carter-cast |
| Matt McCall | Partner | https://shizune.co/investors/profile/matt-mccall |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does David Schonthal invest in?

David Schonthal invests primarily in mHealth, Hospital and Health Care startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did David Schonthal last invest?

The most recent investment recorded for David Schonthal closed in Mar 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co